Search results
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 6 days agoAccording to leading data and analytics company GlobalData’s...reduce exacerbations and manage the...
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
Morningstar· 4 days agoSociety (ATS) 2024 International Conference taking place May 12-22 in San Diego. "We look forward to presenting encouraging data from our Phase 2a COURSE trial in COPD with ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoPDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., May 02, 2024
Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020
CBS 47 Fresno· 6 days agoForesee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia. The Phase 1 clinical trial is a ...
Earnings call: Regeneron reports steady growth, prepares for new launches By Investing.com
Investing.com· 3 days agoThis growth was primarily driven by strong sales of Dupixent and Libtayo, as well as collaboration...
Mesothelioma
Health· 2 days agoRelated conditions include: Chronic obstructive pulmonary disease (COPD): Affects your breathing ability and blocks airflow Coronary artery disease...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 3 days agoRegeneron stock is forming a flat base with a buy point at 998.33, according to MarketSurge. That's...
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 5 days agoAn increase in profits from Dupixent and further uptake of Eylea HD are likely to have aided...
11 Oversold Growth Stocks to Buy Right Now
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we will take a look at the 11 oversold growth stocks to buy right now. To skip our analysis of the recent trends and market activity,...
AstraZeneca to present respiratory disease research at ATS 2024 By Investing.com
Investing.com· 4 days agoDiego, California. The pharmaceutical company announced today that it will showcase 59 abstracts,...
